Skip to main navigation Skip to search Skip to main content

Positron emission tomography (PET) and magnetic resonance imaging (MRI) for assessing tumour resectability in advanced epithelial ovarian, fallopian tube and/or primary peritoneal cancer

  • Jacob P. Hoogendam
  • , Joline F. Roze*
  • , Fleur T. van de Wetering
  • , René Spijker
  • , Leen Verleye
  • , Joan Vlayen
  • , Wouter B. Veldhuis
  • , Rob J P M Scholten
  • , RP Zweemer
  • *Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

This is a protocol for a Cochrane Review (Diagnostic test accuracy). The objectives are as follows: To assess the diagnostic test accuracy of PET(-CT), conventional and diffusion-weighted MRI as an replacement or an add-on to abdominal CT, for predicting tumour resectability at primary debulking surgery in patients with stage III - IV epithelial ovarian, fallopian tube and/or primary peritoneal cancer. To investigate the year of study initiation, the annual surgical caseload and whether surgery is performed by a gynaecological oncologist as possible sources of heterogeneity. For further details, please see Investigations of heterogeneity.

Original languageEnglish
Article numberCD012567
JournalCochrane Database of Systematic Reviews
Volume2017
Issue number3
DOIs
Publication statusPublished - 3 Mar 2017

Fingerprint

Dive into the research topics of 'Positron emission tomography (PET) and magnetic resonance imaging (MRI) for assessing tumour resectability in advanced epithelial ovarian, fallopian tube and/or primary peritoneal cancer'. Together they form a unique fingerprint.

Cite this